| 英文摘要 |
Objectives. People who are living with HIV (PLHIV) can now live longer due to the development and availability of highly active antiretroviral therapy. However, there is a higher prevalence of active smoking among them. In this study, we uses the Framingham risk score (FRS) tool to evaluated risk of coronary heart disease among a group of PLHIV and provided them with a smoking cessation program. Methods. After obtaining informed consent, we collected their descriptive data, including ages, genders, blood pressure, history of diabetes mellitus, current status of smoking, level of total cholesterol (T-CHO), and level of high-density lipoprotein (HDL). FRS were calculated (low risk score: 1-5, moderate risk score: 6-9, high risk score: 10 or above). All the subjects were followed up for 3 years between 2015 and 2018. Results. A total of 152 subjects were recruited. Of these, 139 (91.5%) were male. Forty-seven 47 subjects joined the cessation (SC) group, 38 belonging to a subgroup who fully participated in the program from beginning to end, the uninterrupted (SU) group. Sixty-seven subjects categorized into a non-smoking (NS) group. Moderate risk was noted in 17% in the SC group, 5.3% in the SU group, and 7.5% in the NS group. And 4.3% of SC group were at high risk. At 3-year follow up, FRS showed a significant decrease in risk in the SC group (from 3.70 to 2.28, p<0.005), and an increase (-0.16 to 1.79, p<0.005) in the SU group. The change of NS group was not significant (-0.14 to -0.06, p=0.49). Accumulated FRS had 38% of decrease (from 174 to 107) during these 3 years after smoking cessation program in SC group. On the contrary, there was 12-fold increase in FRS in the SU group. Conclusion. Tobacco cessation may decrease the risk of coronary heart disease. Smoking cessation programs should be promoted among PLHIV to help improve their quality of life and health. |